SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ventas, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97’

On:  Thursday, 2/15/24, at 5:22pm ET   ·   For:  12/31/23   ·   Accession #:  740260-24-67   ·   File #:  1-10989

Previous ‘10-K’:  ‘10-K’ on 2/10/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   47 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/15/24  Ventas, Inc.                      10-K       12/31/23  131:20M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.99M 
 2: EX-4.28     EX-4.28 Description of the Registrants Securities   HTML     43K 
 3: EX-21       EX-21 Subsidiaries of Ventas, Inc.                  HTML   1.22M 
 4: EX-22       EX-22 Guarantor and Issuer Listing                  HTML     38K 
 5: EX-23       EX-23 Consent of Kpmg LLP.                          HTML     36K 
10: EX-97       EX-97 Ventas, Inc. Amended and Restated Policy for  HTML     61K 
                Recoupment of Incentive Comp                                     
 6: EX-31.1     EX-31.1 Section 302 CEO Certification               HTML     38K 
 7: EX-31.2     EX-31.2 Section 302 CFO Certification               HTML     38K 
 8: EX-32.1     EX-32.1 Section 906 CEO Certification               HTML     35K 
 9: EX-32.2     EX-32.2 Section 906 CFO Certification               HTML     35K 
16: R1          Cover                                               HTML    102K 
17: R2          Audit Information                                   HTML     39K 
18: R3          Commitments and Contingencies                       HTML     47K 
19: R4          Consolidated Balance Sheets                         HTML    165K 
20: R5          Consolidated Balance Sheets (Parenthetical)         HTML     47K 
21: R6          Consolidated Statements of Income                   HTML    177K 
22: R7          Consolidated Statements of Comprehensive Income     HTML     74K 
23: R8          Consolidated Statements of Equity                   HTML     93K 
24: R9          Consolidated Statements of Equity (Parenthetical)   HTML     36K 
25: R10         Consolidated Statements of Cash Flows               HTML    198K 
26: R11         Description of Business                             HTML     53K 
27: R12         Accounting Policies                                 HTML    135K 
28: R13         Concentration of Credit Risk                        HTML     85K 
29: R14         Acquisition of Real Estate Property                 HTML     40K 
30: R15         Dispositions and Impairments                        HTML     58K 
31: R16         Loans Receivable and Investments                    HTML     67K 
32: R17         Investment in Unconsolidated Entities               HTML     76K 
33: R18         Intangibles                                         HTML     72K 
34: R19         Other Assets                                        HTML     47K 
35: R20         Senior Notes Payable and Other Debt                 HTML    123K 
36: R21         Fair Value of Financial Instruments                 HTML     75K 
37: R22         Long-Term Compensation                              HTML     74K 
38: R23         Income Taxes                                        HTML    113K 
39: R24         Earnings Per Share                                  HTML     66K 
40: R25         Permanent and Temporary Equity                      HTML     66K 
41: R26         Related Party Transactions                          HTML     45K 
42: R27         Segment Information                                 HTML    250K 
43: R28         Schedule Iii Real Estate and Accumulated            HTML    399K 
                Depreciation                                                     
44: R29         Schedule Iv Mortgage Loans on Real Estate           HTML     72K 
45: R30         Insider Trading Arrangements                        HTML     40K 
46: R31         Accounting Policies (Policies)                      HTML    192K 
47: R32         Description of Business (Tables)                    HTML     48K 
48: R33         Accounting Policies (Tables)                        HTML     50K 
49: R34         Concentration of Credit Risk (Tables)               HTML     75K 
50: R35         Dispositions and Impairments (Tables)               HTML     54K 
51: R36         Loans Receivable and Investments (Tables)           HTML     64K 
52: R37         Investment in Unconsolidated Entities (Tables)      HTML     72K 
53: R38         Intangibles (Tables)                                HTML     78K 
54: R39         Other Assets (Tables)                               HTML     46K 
55: R40         Senior Notes Payable and Other Debt (Tables)        HTML     94K 
56: R41         Fair Value of Financial Instruments (Tables)        HTML     65K 
57: R42         Long-Term Compensation (Tables)                     HTML     64K 
58: R43         Income Taxes (Tables)                               HTML    110K 
59: R44         Commitments and Contingencies (Tables)              HTML     42K 
60: R45         Earnings Per Share (Tables)                         HTML     64K 
61: R46         Permanent and Temporary Equity (Tables)             HTML     59K 
62: R47         Segment Information (Tables)                        HTML    252K 
63: R48         DESCRIPTION OF BUSINESS - Narrative (Details)       HTML     45K 
64: R49         DESCRIPTION OF BUSINESS - Schedule of reportable    HTML     60K 
                business segments and non-segment assets (Details)               
65: R50         ACCOUNTING POLICIES - Schedule of VIEs (Details)    HTML     64K 
66: R51         ACCOUNTING POLICIES - Redeemable OP Unitholder and  HTML     56K 
                Noncontrolling Interests (Details)                               
67: R52         ACCOUNTING POLICIES - Accounting for Historic and   HTML     44K 
                New Markets Tax Credits (Details)                                
68: R53         ACCOUNTING POLICIES - Accounting for Real Estate    HTML     38K 
                Acquisitions (Details)                                           
69: R54         ACCOUNTING POLICIES - Deferred Financing Costs      HTML     37K 
                (Details)                                                        
70: R55         ACCOUNTING POLICIES - Fair Value of Financial       HTML     44K 
                Instruments (Details)                                            
71: R56         ACCOUNTING POLICIES - Revenue Recognition           HTML     36K 
                (Details)                                                        
72: R57         ACCOUNTING POLICIES - Segments (Details)            HTML     36K 
73: R58         ACCOUNTING POLICIES - Government Assistance         HTML     37K 
                (Details)                                                        
74: R59         CONCENTRATION OF CREDIT RISK - Narrative (Details)  HTML    117K 
75: R60         CONCENTRATION OF CREDIT RISK - Triple-Net Leased    HTML     53K 
                Properties (Details)                                             
76: R61         CONCENTRATION OF CREDIT RISK - Minimum Rents        HTML     64K 
                (Details)                                                        
77: R62         CONCENTRATION OF CREDIT RISK - Kindred Lease        HTML     50K 
                (Details)                                                        
78: R63         CONCENTRATION OF CREDIT RISK - Brookdale            HTML     44K 
                Transactions (Details)                                           
79: R64         CONCENTRATION OF CREDIT RISK - Senior Housing       HTML     53K 
                Operating Portfolio (Details)                                    
80: R65         ACQUISITION OF REAL ESTATE PROPERTY - 2022          HTML     46K 
                Acquisitions (Details)                                           
81: R66         ACQUISITION OF REAL ESTATE PROPERTY - 2021          HTML     58K 
                Acquisitions (Details)                                           
82: R67         ACQUISITION OF REAL ESTATE PROPERTY - 2024          HTML     40K 
                Acquisitions (Details)                                           
83: R68         DISPOSITIONS AND IMPAIRMENTS - 2023 Disposition     HTML     61K 
                Activity (Details)                                               
84: R69         DISPOSITIONS AND IMPAIRMENTS - 2022 Dispositions    HTML     57K 
                Activity (Details)                                               
85: R70         DISPOSITIONS AND IMPAIRMENTS - 2021 Dispositions    HTML     52K 
                Activity (Details)                                               
86: R71         DISPOSITIONS AND IMPAIRMENTS - Assets Held For      HTML     63K 
                Sale and Impairment (Details)                                    
87: R72         LOANS RECEIVABLE AND INVESTMENTS - Narrative        HTML     36K 
                (Details)                                                        
88: R73         LOANS RECEIVABLE AND INVESTMENTS - Schedule of      HTML     82K 
                Loans Receivable and Investments (Details)                       
89: R74         LOANS RECEIVABLE AND INVESTMENTS - 2022 Activity    HTML     55K 
                (Details)                                                        
90: R75         LOANS RECEIVABLE AND INVESTMENTS - 2023 Activity    HTML     41K 
                (Details)                                                        
91: R76         INVESTMENT IN UNCONSOLIDATED ENTITIES - Schedule    HTML     60K 
                of Investments in Unconsolidated Subsidiaries                    
                (Details)                                                        
92: R77         INVESTMENT IN UNCONSOLIDATED ENTITIES - Narrative   HTML     79K 
                (Details)                                                        
93: R78         INVESTMENT IN UNCONSOLIDATED ENTITIES - Schedule    HTML     93K 
                of Combined Summarized Balance Sheets of                         
                Unconsolidated Entities (Details)                                
94: R79         INVESTMENT IN UNCONSOLIDATED ENTITIES - Schedule    HTML     63K 
                of Combined Summarized Statement of Income of                    
                Unconsolidated Entities (Details)                                
95: R80         INTANGIBLES - Summary of Intangibles (Details)      HTML     87K 
96: R81         INTANGIBLES - Goodwill (Details)                    HTML     44K 
97: R82         Other Assets (Details)                              HTML     57K 
98: R83         SENIOR NOTES PAYABLE AND OTHER DEBT - Summary of    HTML    151K 
                Senior Notes Payable and Other Debt (Details)                    
99: R84         SENIOR NOTES PAYABLE AND OTHER DEBT - Credit        HTML     91K 
                Facilities and Unsecured Term Loans (Details)                    
100: R85         SENIOR NOTES PAYABLE AND OTHER DEBT - Senior Notes  HTML    128K  
                (Details)                                                        
101: R86         SENIOR NOTES PAYABLE AND OTHER DEBT - Mortgages     HTML    109K  
                (Details)                                                        
102: R87         SENIOR NOTES PAYABLE AND OTHER DEBT - Scheduled     HTML     66K  
                Maturities (Details)                                             
103: R88         SENIOR NOTES PAYABLE AND OTHER DEBT - Derivatives   HTML     67K  
                and Hedging (Details)                                            
104: R89         FAIR VALUE OF FINANCIAL INSTRUMENTS - Narrative     HTML     57K  
                (Details)                                                        
105: R90         FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of   HTML    108K  
                carrying amounts and fair values of our financial                
                instruments either recorded or disclosed on a                    
                recurring basis (Details)                                        
106: R91         Long-Term Compensation (Details)                    HTML    194K  
107: R92         INCOME TAXES - Tax Treatment of Distributions and   HTML     75K  
                Consolidated Benefit for Income Taxes (Details)                  
108: R93         INCOME TAXES - Narrative (Details)                  HTML     73K  
109: R94         INCOME TAXES - Reconciliation of Income Taxes       HTML     54K  
                (Details)                                                        
110: R95         INCOME TAXES - Tax Effects of Temporary             HTML     46K  
                Differences and Carryforwards Included in Net                    
                Deferred Tax Liabilities (Details)                               
111: R96         INCOME TAXES - Unrecognized Tax Benefits (Details)  HTML     41K  
112: R97         Commitments and Contingencies (Details)             HTML     64K  
113: R98         Earnings Per Share (Details)                        HTML    113K  
114: R99         PERMANENT AND TEMPORARY EQUITY - Narrative          HTML     66K  
                (Details)                                                        
115: R100        PERMANENT AND TEMPORARY EQUITY - Accumulated Other  HTML     45K  
                Comprehensive Loss (Details)                                     
116: R101        PERMANENT AND TEMPORARY EQUITY - Redeemable OP      HTML     55K  
                Unitholder and Noncontrolling Interest (Details)                 
117: R102        Related Party Transactions (Details)                HTML    123K  
118: R103        SEGMENT INFORMATION - Narrative (Details)           HTML     38K  
119: R104        SEGMENT INFORMATION - Income Statement by Segment   HTML    162K  
                (Details)                                                        
120: R105        SEGMENT INFORMATION - Assets (Details)              HTML     55K  
121: R106        SEGMENT INFORMATION - Capital Expenditures          HTML     45K  
                (Details)                                                        
122: R107        SEGMENT INFORMATION - Geographic Information        HTML     55K  
                (Details)                                                        
123: R108        SCHEDULE III REAL ESTATE AND ACCUMULATED            HTML     64K  
                DEPRECIATION - Rollforward (Details)                             
124: R109        SCHEDULE III REAL ESTATE AND ACCUMULATED            HTML    394K  
                DEPRECIATION - Properties (Details)                              
125: R110        SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE - Loans   HTML     66K  
                (Details)                                                        
126: R111        SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE -         HTML     54K  
                Mortgage Loan Reconciliation (Details)                           
128: XML         IDEA XML File -- Filing Summary                      XML    237K  
131: XML         XBRL Instance -- vtr-20231231_htm                    XML   4.29M  
127: EXCEL       IDEA Workbook of Financial Report Info              XLSX    317K  
12: EX-101.CAL  XBRL Calculations -- vtr-20231231_cal                XML    288K 
13: EX-101.DEF  XBRL Definitions -- vtr-20231231_def                 XML   1.70M 
14: EX-101.LAB  XBRL Labels -- vtr-20231231_lab                      XML   3.49M 
15: EX-101.PRE  XBRL Presentations -- vtr-20231231_pre               XML   2.35M 
11: EX-101.SCH  XBRL Schema -- vtr-20231231                          XSD    388K 
129: JSON        XBRL Instance as JSON Data -- MetaLinks              847±  1.29M  
130: ZIP         XBRL Zipped Folder -- 0000740260-24-000067-xbrl      Zip   1.06M  


‘EX-97’   —   EX-97 Ventas, Inc. Amended and Restated Policy for Recoupment of Incentive Comp


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
AS APPROVED AND ADOPTED
OCTOBER 12, 2023
VENTAS INC.
AMENDED AND RESTATED
POLICY FOR RECOUPMENT OF INCENTIVE COMPENSATION
        This Amended and Restated Policy for Recoupment of Incentive Compensation (“Policy”) has been adopted by the Compensation Committee of the Board of Directors (the “Board”) of Ventas Inc. (the “Company”) on October 12, 2023 with effect on December 1, 2023. This Policy provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under U.S. federal securities laws in accordance with the terms and conditions set forth herein. This Policy is intended to comply with the requirements of Section 10D of the Exchange Act (as defined below) and Section 303A.14 of the NYSE Listed Company Manual (the “Listing Rule”).

1.Definitions. For the purposes of this Policy, the following terms shall have the meanings set forth below.

(a)Committee” means the compensation committee of the Board or any successor committee thereof.

(b)Covered Compensation” means any Incentive-based Compensation “received” by a Covered Executive during the applicable Recoupment Period; provided that:

(i)    such Incentive-based Compensation was received by such Covered Executive (A) on or after the Effective Date, (B) after he or she commenced service as an Executive Officer and (C) while the Company had a class of securities publicly listed on a United States national securities exchange; and

(ii)    such Covered Executive served as an Executive Officer at any time during the performance period     applicable to such Incentive-based Compensation.

For purposes of this Policy, Incentive-based     Compensation is “received” by a Covered Executive during the fiscal period in which the Financial Reporting Measure applicable to such Incentive-based Compensation (or portion thereof) is attained, even if the payment or grant of such Incentive-based Compensation is made thereafter.

(c)Covered Executive” means any current or former Executive Officer.
(d)Effective Date” means October 2, 2023.

(e)Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

(f)Executive Officer” means, with respect to the Company, (i) its president, (ii) its principal financial officer, (iii) its principal accounting officer (or if there is no such accounting officer, its controller), (iv) any vice-president in charge of a principal business unit, division or function (such as sales, administration or finance), (v) any other officer who performs a policy-making function for the Company (including any officer of the Company’s parent(s) or subsidiaries if they perform policy-making functions for the Company) and (vi) any other person who performs similar policy-making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. The determination as to an individual’s status as an Executive Officer shall be made by the Committee and such determination shall be final, conclusive and binding on such individual and all other interested persons.
(g)Financial Reporting Measure” means any (i) measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, (ii) stock price measure or (iii) total shareholder return measure (and any measures that are derived wholly or in part from any measure referenced in clause (i), (ii) or (iii) above). For the avoidance of doubt, any such measure does not need to be presented within the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission to constitute a Financial Reporting Measure.
(h)Financial Restatement” means a restatement of the Company’s financial statements due to the Company’s material noncompliance with any financial reporting requirement under U.S. federal securities laws that is required in order to correct:
(i)    an error in previously issued financial statements that is material to the previously issued financial     statements; or



(ii)     an error that would result in a material misstatement if the error were (A) corrected in the current     period or (B) left uncorrected in the current period.

For purposes of this Policy, a Financial Restatement shall not be deemed to occur in the event of a revision of the Company’s financial statements due to an out-of-period adjustment (i.e., when the error is immaterial to the previously issued financial statements and the correction of the error is also immaterial to the current period) or a retrospective (1) application of a change in accounting principles; (2) revision to reportable segment information due to a change in the structure of the Company’s internal organization; (3) reclassification due to a discontinued operation; (4) application of a change in reporting entity, such as from a reorganization of entities under common control; or (5) revision for stock splits, reverse stock splits, stock dividends or other changes in capital structure.

(i)Incentive-based Compensation” means any compensation (including, for the avoidance of doubt, any cash or equity or equity-based compensation, whether deferred or current) that is granted, earned and/or vested based wholly or in part upon the achievement of a Financial Reporting Measure. For purposes of this Policy, “Incentive-based Compensation” shall also be deemed to include any amounts which were determined based on (or were otherwise calculated by reference to) Incentive-based Compensation (including, without limitation, any amounts under any long-term disability, life insurance or supplemental retirement or severance plan or agreement or any notional account that is based on Incentive-based Compensation, as well as any earnings accrued thereon).
(j)NYSE” means the New York Stock Exchange, or any successor thereof.

(k)Recoupment Period” means the three fiscal years completed immediately preceding the date of any applicable Recoupment Trigger Date. Notwithstanding the foregoing, the Recoupment Period additionally includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years, provided that a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine (9) to twelve (12) months would be deemed a completed fiscal year.
(l)Recoupment Trigger Date” means the earlier of (i) the date that the Board (or a committee thereof or the officer(s) of the Company authorized to take such action if Board action is not required) concludes, or reasonably should have concluded, that the Company is required to prepare a Financial Restatement, and (ii) the date on which a court, regulator or other legally authorized body directs the Company to prepare a Financial Restatement.

2.Recoupment of Erroneously Awarded Compensation.

(a)In the event of a Financial Restatement, if the amount of any Covered Compensation received by a Covered Executive (the “Awarded Compensation”) exceeds the amount of such Covered Compensation that would have otherwise been received by such Covered Executive if calculated based on the Financial Restatement (the “Adjusted Compensation”), the Company shall reasonably promptly recover from such Covered Executive an amount equal to the excess of the Awarded Compensation over the Adjusted Compensation, each calculated on a pre-tax basis (such excess amount, the “Erroneously Awarded Compensation”).
(b) If (i) the Financial Reporting Measure applicable to the relevant Covered Compensation is stock price or total shareholder return (or any measure derived wholly or in part from either of such measures) and (ii) the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the Financial Restatement, then the amount of Erroneously Awarded Compensation shall be determined (on a pre-tax basis) based on the Company’s reasonable estimate of the effect of the Financial Restatement on the Company’s stock price or total shareholder return (or the derivative measure thereof) upon which such Covered Compensation was received.
(c)For the avoidance of doubt, the Company’s obligation to recover Erroneously Awarded Compensation is not dependent on (i) if or when the restated financial statements are filed; or (ii) any fault of any Covered Executive for the accounting errors or other actions leading to a Financial Restatement.
(d)Notwithstanding anything to the contrary in Sections 2(a) through (c) hereof, the Company shall not be required to recover any Erroneously Awarded Compensation if both (x) the conditions set forth in either of the following clauses (i) or (ii) are satisfied and (y) the Committee (or a majority of the independent directors serving on the Board) has determined that recovery of the Erroneously Awarded Compensation would be impracticable:

(i)the direct expense paid to a third party to assist in enforcing the recovery of the Erroneously Awarded Compensation under this Policy would exceed the amount of such Erroneously
2

    


Awarded Compensation to be recovered; provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation pursuant to this Section 2(d), the Company shall have first made a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to make such recovery and provide that documentation to the NYSE; or

(ii)recovery of the Erroneously Awarded Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Sections 401(a)(13) or 411(a) of the U.S. Internal Revenue Code of 1986, as amended (the “Code”).

(e)The Company shall not indemnify any Covered Executive, directly or indirectly, for any losses that such Covered Executive may incur in connection with the recovery of Erroneously Awarded Compensation pursuant to this Policy, including through the payment of insurance premiums or gross-up payments.

(f)The Committee shall determine, in its sole discretion, the manner and timing in which any Erroneously Awarded Compensation shall be recovered from a Covered Executive in accordance with applicable law, including, without limitation, by (i) requiring reimbursement of Covered Compensation previously paid in cash; (ii) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity or equity-based awards; (iii) offsetting the Erroneously Awarded Compensation amount from any compensation otherwise owed by the Company or any of its affiliates to the Covered Executive; (iv) cancelling outstanding vested or unvested equity or equity-based awards; and/or (v) taking any other remedial and recovery action permitted by applicable law. For the avoidance of doubt, except as set forth in Section 2(d), in no event may the Company accept an amount that is less than the amount of Erroneously Awarded Compensation; provided that, to the extent necessary to avoid any adverse tax consequences to the Covered Executive pursuant to Section 409A of the Code, any offsets against amounts under any nonqualified deferred compensation plans (as defined under Section 409A of the Code) shall be made in compliance with Section 409A of the Code.

3.Administration. This Policy shall be administered by the Committee. All decisions of the Committee shall be final, conclusive and binding upon the Company and the Covered Executives, their beneficiaries, heirs, executors, administrators and any other legal representative. The Committee shall have full power and authority to (i) administer and interpret this Policy; (ii) correct any defect, supply any omission and reconcile any inconsistency in this Policy; and (iii) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of this Policy and to comply with applicable law (including Section 10D of the Exchange Act) and applicable stock market or exchange rules and regulations. Notwithstanding anything to the contrary contained herein, to the extent permitted by Section 10D of the Exchange Act and the Listing Rule, the Board may, in its sole discretion, at any time and from time to time, administer this Policy in the same manner as the Committee.

4.Amendment/Termination. Subject to Section 10D of the Exchange Act and the Listing Rule, this Policy may be amended or terminated by the Committee at any time. To the extent that any applicable law, or stock market or exchange rules or regulations require recovery of Erroneously Awarded Compensation in circumstances in addition to those specified herein, nothing in this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover Erroneously Awarded Compensation to the fullest extent required by such applicable law, stock market or exchange rules and regulations. Unless otherwise required by applicable law, this Policy shall no longer be effective from and after the date that the Company no longer has a class of securities publicly listed on a United States national securities exchange.

5.Interpretation. Notwithstanding anything to the contrary herein, this Policy is intended to comply with the requirements of Section 10D of the Exchange Act and the Listing Rule (and any applicable regulations, administrative interpretations or stock market or exchange rules and regulations adopted in connection therewith). The provisions of this Policy shall be interpreted in a manner that satisfies such requirements and this Policy shall be operated accordingly. If any provision of this Policy would otherwise frustrate or conflict with this intent, the provision shall be interpreted and deemed amended so as to avoid such conflict.
6.Other Compensation Clawback/Recoupment Rights. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies, rights or requirements with respect to the clawback or recoupment of any compensation that may be available to the Company pursuant to the terms of any other recoupment or clawback policy of the Company (or any of its affiliates) that may be in effect from time to time, any provisions in any employment agreement, offer letter, equity plan, equity award agreement or similar plan or agreement, and any other legal remedies available to the Company, as well as applicable law, stock market or exchange rules, listing standards or regulations; provided, however, that any amounts recouped or clawed back under any other policy that would be recoupable under this Policy shall count toward any required clawback or recoupment under this Policy and vice versa.
3

    



7. Exempt Compensation. Notwithstanding anything to the contrary herein, the Company has no obligation under this Policy to seek recoupment of amounts paid to a Covered Executive which are granted, vested or earned based solely upon the occurrence or non-occurrence of nonfinancial events. Such exempt compensation includes, without limitation, base salary, time-vesting awards, compensation awarded on the basis of the achievement of metrics that are not Financial Reporting Measures or compensation awarded solely at the discretion of the Committee or the Board, provided that such amounts are in no way contingent on, and were not in any way granted on the basis of, the achievement of any Financial Reporting Measure performance goal.
8.Miscellaneous.

(a)Any applicable award agreement or other document setting forth the terms and conditions of any compensation covered by this Policy shall be deemed to include the restrictions imposed herein and incorporate this Policy by reference and, in the event of any inconsistency, the terms of this Policy will govern. For the avoidance of doubt, this Policy applies to all compensation that is received on or after the Effective Date, regardless of the date on which the award agreement or other document setting forth the terms and conditions of the Covered Executive’s compensation became effective, including, without limitation, compensation received under the Ventas, Inc. 2012 Incentive Plan or the Ventas, Inc. 2022 Incentive Plan, and any successor plan to each of the foregoing.

(b)This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.
(c)All issues concerning the construction, validity, enforcement and interpretation of this Policy and all related documents, including, without limitation, any employment agreement, offer letter, equity award agreement or similar agreement, shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware.
(d)The Covered Executives, their beneficiaries, heirs, executors, administrators and any other legal representative and the Company shall initially attempt to resolve all claims, disputes or controversies arising under, out of or in connection with this Policy by conducting good faith negotiations amongst themselves. To ensure the timely and economical resolution of disputes that arise in connection with this Policy, any and all disputes, claims or causes of action arising from or relating to the enforcement, performance or interpretation of this Policy shall be resolved to the fullest extent permitted by law by final, binding and confidential arbitration, by a single arbitrator, in Chicago, Illinois, conducted by Judicial Arbitration and Mediation Services, Inc. (“JAMS”) under the applicable JAMS rules. To the fullest extent permitted by law, the Covered Executives, their beneficiaries, heirs, executors, administrators and any other legal representative and the Company, shall waive (and shall hereby be deemed to have waived) (1) the right to resolve any such dispute through a trial by jury or judge or administrative proceeding; and (2) any objection to arbitration taking place in Chicago, Illinois. The arbitrator shall: (i) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (ii) issue a written arbitration decision, to include the arbitrator’s essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that any party would be entitled to seek in a court of law. Any such award rendered shall be enforceable by any court having jurisdiction and, to the fullest extent permitted by law, the Covered Executives, their beneficiaries, heirs, executors, administrators and any other legal representative and the Company shall waive (and shall hereby be deemed to have waived) the right to resolve any such dispute regarding enforcement of such award through a trial by jury.
(e)If any provision of this Policy is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable law and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.



4

    

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/15/248-K
For Period end:12/31/23
12/1/23
10/12/234
10/2/234
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  Ventas, Inc.                      424B5                  2:739K                                   Toppan Merrill/FA
 2/20/24  Ventas, Inc.                      S-3ASR      2/20/24    7:1.1M                                   Toppan Merrill/FA


45 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/12/23  Ventas, Inc.                      8-K:1,2,9   9/06/23   11:1M                                     Toppan Merrill/FA
 8/04/23  Ventas, Inc.                      10-Q        6/30/23   81:12M
 6/13/23  Ventas, Inc.                      8-K:1,2,3,9 6/08/23   11:1.1M                                   Toppan Merrill/FA
 5/09/23  Ventas, Inc.                      10-Q        3/31/23   80:9.5M
 2/10/23  Ventas, Inc.                      10-K       12/31/22  138:40M
 8/05/22  Ventas, Inc.                      10-Q        6/30/22   83:11M
 6/30/22  Ventas, Inc.                      8-K:1,2,9   6/27/22   11:1.1M                                   Toppan Merrill/FA
 6/01/22  Ventas, Inc.                      8-K:5,8,9   5/25/22   11:387K                                   Toppan Merrill/FA
 2/18/22  Ventas, Inc.                      10-K       12/31/21  121:21M
11/09/21  Ventas, Inc.                      8-K:1,9    11/08/21   12:926K                                   Toppan Merrill/FA
11/05/21  Ventas, Inc.                      10-Q        9/30/21   85:11M
 8/20/21  Ventas, Inc.                      8-K:8,9     8/20/21   13:667K                                   Toppan Merrill/FA
 6/28/21  Ventas, Inc.                      8-K:1,7,9   6/28/21   13:4M                                     Toppan Merrill/FA
 2/23/21  Ventas, Inc.                      10-K       12/31/20  125:68M
 2/02/21  Ventas, Inc.                      8-K:1,2,5,9 1/29/21   12:1.5M                                   Toppan Merrill/FA
 5/08/20  Ventas, Inc.                      10-Q        3/31/20   85:10M
 4/01/20  Ventas, Inc.                      8-K:8,9     3/30/20   13:662K                                   Toppan Merrill/FA
 2/24/20  Ventas, Inc.                      10-K       12/31/19  133:77M
 8/21/19  Ventas, Inc.                      8-K:8,9     8/12/19   14:684K                                   Toppan Merrill/FA2
 7/03/19  Ventas, Inc.                      8-K:8,9     7/03/19    5:575K                                   Toppan Merrill/FA
 2/26/19  Ventas, Inc.                      8-K:8,9     2/19/19    4:647K                                   Toppan Merrill/FA
 8/15/18  Ventas, Inc.                      8-K:8,9     8/15/18    5:586K                                   Toppan Merrill/FA
 4/27/18  Ventas, Inc.                      10-Q        3/31/18   88:13M
 2/23/18  Ventas, Inc.                      8-K:8,9     2/13/18    6:1.1M                                   Toppan Merrill/FA
 2/09/18  Ventas, Inc.                      10-K       12/31/17  134:62M
 4/28/17  Ventas, Inc.                      10-Q        3/31/17   93:14M
 3/29/17  Ventas, Inc.                      8-K:8,9     3/22/17    4:682K                                   Toppan Merrill/FA
 2/14/17  Ventas, Inc.                      10-K       12/31/16  125:64M
 9/21/16  Ventas, Inc.                      8-K:8,9     9/14/16    4:578K                                   Toppan Merrill/FA
 2/12/16  Ventas, Inc.                      10-K       12/31/15  121:65M
 7/16/15  Ventas, Inc.                      8-K:8,9     7/16/15    5:1.2M                                   Toppan Merrill/FA
 2/13/15  Ventas, Inc.                      10-K       12/31/14  120:114M
 1/14/15  Ventas, Inc.                      8-K:8,9     1/14/15    3:587K                                   Toppan Merrill/FA
10/24/14  Ventas, Inc.                      10-Q        9/30/14   83:23M
 9/29/14  Ventas, Inc.                      8-K:5,9     9/23/14    4:261K                                   Toppan Merrill/FA
 4/17/14  Ventas, Inc.                      8-K:8,9     4/17/14    3:629K                                   Toppan Merrill/FA
 9/26/13  Ventas, Inc.                      8-K:8,9     9/26/13    3:645K                                   Toppan Merrill/FA
 8/07/12  Ventas, Inc.                      S-8         8/07/12    8:297K                                   Toppan Merrill/FA
 5/23/12  Ventas, Inc.                      8-K:5,8,9   5/17/12    3:248K                                   Toppan Merrill/FA
 4/27/12  Ventas, Inc.                      10-Q        3/31/12   83:17M                                    Toppan Merrill-FA
 8/05/11  Ventas, Inc.                      10-Q        6/30/11   80:8.5M                                   Donnelley … Solutions/FA
 3/24/11  Ventas, Inc.                      8-K:5,9     3/22/11    3:212K                                   Donnelley … Solutions/FA
 2/27/09  Ventas, Inc.                      10-K       12/31/08   24:4.3M                                   Donnelley … Solutions/FA
 5/29/02  Ventas LP Realty LLC              S-4                   24:1.1M                                   Donnelley … Solutions/FA
 8/19/97  Nationwide Health Properties, LLC 8-K:7       8/19/97    3:344K                                   Donnelley Fin’l S… 05/FA
Top
Filing Submission 0000740260-24-000067   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 12:57:08.3pm ET